The exciting potential of immunotherapy for cancer treatment continues its exploration and here, Drug Target Review investigates three of the latest pre-clinical developments in immuno-oncology research.
List view / Grid view
Scientists suggest the PCSK9Q152H gene variant may act as a “fountain of youth”, allowing people to live longer, healthier lives.
An artificial intelligence platform available online has been designed to help researchers track the genetics of SARS-CoV-2 as it moves from person to person.
A study has revealed that the compound cannabigerol (CBG) is effective as an antibacterial in mice, by preventing bacteria from forming biofilms.
Researchers have uncovered new antibiotics which prevent bacteria from multiplying, offering a strategy to fight infections.
A compound that has antimicrobial properties has been found by researchers, which could be used to combat drug-resistant infections.
A study has revealed an enzyme in bacteria that produces a molecule which is toxic to other bacteria and shows promise as an antibiotic substitute.
The team used techniques used by physicists along with highly specialised equipment to investigate deep into the bacterial membrane...
Researchers have developed a new theory on Huntington's disease which is being welcomed for showing promise to open new avenues of drug development for the condition...
Canadian researchers have identified several unknown chemicals that were consistently associated with babies who had cystic fibrosis (CF), including two different drug and environmental compounds the infants secreted in sweat at much lower concentration levels...